Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Bevacizumab-associated glomerular microangiopathy.

Person F, Rinschen MM, Brix SR, Wulf S, Noriega MLM, Fehrle W, Schmitz J, Schwarz A, Ivanyi P, Steinmetz OM, Reinhard L, Hoxha E, Zipfel PF, Bräsen JH, Wiech T.

Mod Pathol. 2019 May;32(5):684-700. doi: 10.1038/s41379-018-0186-4. Epub 2018 Dec 14.

PMID:
30552416
2.

Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy.

Pfister F, Amann K, Daniel C, Klewer M, Büttner A, Büttner-Herold M.

Histopathology. 2018 Dec;73(6):990-1001. doi: 10.1111/his.13716. Epub 2018 Sep 25.

PMID:
30014486
3.
4.

Thrombotic microangiopathy with intraglomerular IgM pseudothrombi in Waldenström macroglobulinemia and IgM monoclonal gammopathy.

Tan SYS, Sibley RK, Belani S, Iwasaki S, Yankulin L, Jonelis T, Higgins JPT, Kambham N, Troxell ML.

J Nephrol. 2018 Dec;31(6):907-918. doi: 10.1007/s40620-018-0544-9. Epub 2018 Oct 17.

PMID:
30334170
5.

[A case of thrombotic microangiopathy with glomerular subendothelial IgA deposition due to bevacizumab].

Tomita M, Ochiai M, Shu S, Yamauchi Y, Shihara H, Ogata A, Fujisawa N, Yanai Y, Kamata T, Iehara N.

Nihon Jinzo Gakkai Shi. 2014;56(5):612-7. Japanese.

PMID:
25130034
6.

A clinicopathologic study of thrombotic microangiopathy in the setting of IgA nephropathy.

Chang A, Kowalewska J, Smith KD, Nicosia RF, Alpers CE.

Clin Nephrol. 2006 Dec;66(6):397-404.

PMID:
17176910
7.

Progressive bevacizumab-associated renal thrombotic microangiopathy.

Uy AL, Simper NB, Champeaux AL, Perkins RM.

NDT Plus. 2009 Feb;2(1):36-9. doi: 10.1093/ndtplus/sfn168. Epub 2008 Nov 12.

8.

Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.

Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D'Amico G.

Am J Kidney Dis. 1997 Sep;30(3):404-12.

PMID:
9292570
9.

Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report.

Yamada R, Okawa T, Matsuo K, Suzuki M, Mori N, Mori K.

BMC Nephrol. 2019 Jan 11;20(1):14. doi: 10.1186/s12882-018-1194-9.

10.

VEGF inhibition and renal thrombotic microangiopathy.

Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE.

N Engl J Med. 2008 Mar 13;358(11):1129-36. doi: 10.1056/NEJMoa0707330.

11.

Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye.

Schraermeyer U, Julien S.

Graefes Arch Clin Exp Ophthalmol. 2012 Sep;250(9):1303-13. doi: 10.1007/s00417-012-2055-z. Epub 2012 May 22.

PMID:
22614910
12.

Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?

Seida A, Wada J, Morita Y, Baba M, Eguchi J, Nishimoto N, Okino T, Ichimura K, Yoshino T, Makino H.

Am J Kidney Dis. 2004 Jan;43(1):E3-9.

PMID:
14712466
13.

Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis.

Brackman D, Sartz L, Leh S, Kristoffersson AC, Bjerre A, Tati R, Frémeaux-Bacchi V, Karpman D.

Nephrol Dial Transplant. 2011 Oct;26(10):3399-403. doi: 10.1093/ndt/gfr422. Epub 2011 Aug 1. Erratum in: Nephrol Dial Transplant. 2017 Mar 1;32(3):584.

PMID:
21810760
14.

Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.

Yılmaz S, Özçakar ZB, Taktak A, Kiremitçi S, Ensari A, Dinçaslan H, Yalçınkaya F.

Pediatr Nephrol. 2016 Jun;31(6):1029-32. doi: 10.1007/s00467-016-3355-z. Epub 2016 Feb 29.

PMID:
26928310
15.

Platelets and capillary injury in acute humoral rejection of renal allografts.

Meehan SM, Limsrichamrern S, Manaligod JR, Junsanto T, Josephson MA, Thistlethwaite JR, Haas M.

Hum Pathol. 2003 Jun;34(6):533-40.

PMID:
12827606
16.

Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.

Lajoie G, Kumar S, Min KW, Silva FG.

Am J Surg Pathol. 1995 Sep;19(9):1021-8.

PMID:
7661275
17.

A COL4A5 mutation with glomerular disease and signs of chronic thrombotic microangiopathy.

Wuttke M, Seidl M, Malinoc A, Prischl FC, Kuehn EW, Walz G, Köttgen A.

Clin Kidney J. 2015 Dec;8(6):690-4. doi: 10.1093/ckj/sfv091. Epub 2015 Sep 29.

18.

Thrombotic microangiopathy and acute kidney injury following vivax malaria.

Sinha A, Singh G, Bhat AS, Mohapatra S, Gulati A, Hari P, Samantaray JC, Dinda AK, Agarwal SK, Bagga A.

Clin Exp Nephrol. 2013 Feb;17(1):66-72. doi: 10.1007/s10157-012-0656-9. Epub 2012 Jul 4.

PMID:
22752395
19.

Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature.

Usui J, Glezerman IG, Salvatore SP, Chandran CB, Flombaum CD, Seshan SV.

Hum Pathol. 2014 Sep;45(9):1918-27. doi: 10.1016/j.humpath.2014.05.015. Epub 2014 Jun 12. Review.

PMID:
25087655
20.

Histopathological manifestations of membranoproliferative glomerulonephritis and glomerular expression of plasmalemmal vesicle-associated protein-1 in a patient with polycythemia vera.

Nishi Y, Namikoshi T, Sasaki T, Tokura T, Nagasu H, Nakanishi H, Kozuka Y, Kashihara N.

Clin Nephrol. 2010 Nov;74(5):393-8.

PMID:
20979949

Supplemental Content

Support Center